Explore additional resources describing the challenges of therapeutic delivery and TriNav^® as a solution.

Videos Case Presentations Imaging Library Clinical Summaries Podcasts Publications Using TriNav

Videos

Favorable Particle-Fluid Dynamics With PEDD™ and SmartValve® Technology

In a hepatic arterial model, a Pressure-Enabled Drug Delivery^TM device that generated turbulent particle flow demonstrated 62% better microsphere distribution to downstream arterial branches than a traditional microcatheter.

PEDD™ Approach: Helping to Overcome Barriers to Effective Therapy Delivery

PEDD™ Approach

Evidence demonstrates that the PEDD™ approach offers more precise tumor targeting, increased therapy delivery and better tumor response than traditional microcatheters.

Drug Infusion Approaches for Solid Liver Tumors

TriNav Device

The challenges to effective therapeutic delivery using traditional drug infusion approaches and the SmartValve™ technology solution.

Ultrasound Imaging of TriNav Infusion System

Ultrasound Imaging of TriNav Infusion System

See how SmartValve™ technology expands and contracts in sync with the cardiac cycle to help control flow and modulate pressure.

TriNav Infusion System: Clinical Essentials

TriNav Infusion System: Clinical Essentials

Data from a study comparing the use of end-hole and microvalve infusion catheters in patients undergoing drug-eluting microspheres-TACE for HCC show improved tumor response with the microvalve infusion catheter.

TriNav Vascular Resistance Modeling

TriNav Vascular Resistance Modeling

Demonstration of Pressure-Enabled Drug Delivery™ (PEDD™) infusion performance.

Liver Tumor Microenvironment

Our Pressure-Enabled Drug Delivery™ method of administration helps overcome intratumoral pressure to improve therapy delivery in liver tumors.

Case Presentations on Cancer Treatment Using TriNav Infusion System

Y90 Treatment via Pressure-Enabled Drug Delivery in Patient with HCC & Dosimetry Analysis Using MIM SurePlan Y90

Right Hepatic Glass Y90 Treatment Using TriNav^® in Patient with HCC Shows Improved Tumor Targeting Compared to Standard Microcatheter Used in Mapping Procedure

Case Presentation Right Hepatic Glass Y90

Pressure-Enabled Conventional TACE for Hepatocellular Carcinoma: A Case Presentation

Improved Tumor Perfusion in Hepatocellular Carcinoma

The Use of TriNav to Improve Perfusion in Setting of Iatrogenic Complication

Improved Tumor Uptake when Using TriNav^® Infusion System in Y-90 Mapping Procedure as Compared to Standard Microcatheter

Precision and Accuracy of the TriNav^® Infusion System in Y-90 Mapping and Therapeutic Delivery

Imaging Library for Cancer Treatment Using TriNav Infusion System

TriNav Improves Y90 Tumor Perfusion in Multicentric, Multilobar HCC

PEDD™ DEB-TACE in Patient with HCC

Improved Perfusion with TriNav^® Compared to a Conventional Angiographic Catheter in Metastatic Renal Cell Carcinoma

Y90 Mapping Procedure using TriNav^® in Patient with Metastatic Neuroendocrine Tumor

Response to Microsphere Embolization Using the TriNav^® Infusion System in Hypovascular Leiomyosarcoma Metastases

Right Hepatic Y90 Radiation Segmentectomy using TriNav^® in Patient with Hepatocellular Carcinoma

Super-Selective DEB-TACE Performed Using TriNav^® in Patient with Hepatocellular Carcinoma

Improved Tumor Uptake when Using a TriNav^® Infusion
System in a Y-90 Mapping Procedure

Clinical Summaries for Cancer Treatment Using PEDD Approach

Innovation in Catheter Design for Intra-Arterial Liver Cancer Treatments Results in Favorable Particle-Fluid Dynamics

Multi-Center Registry Study of the Safety, Feasibility, and Outcomes of Pressure-Enabled Drug Delivery in DEB-TACE for Patients with HCC

Pressure Enabled Drug Delivery™ — Clinical Evidence. Resonance of multiple clinical studies with different therapeutics

Pressure-Enabled Drug Delivery^TM Improves Tumor Targeting in Liver Radioembolization with Resin Microspheres

The Impact of Pressure-Enabled Drug Delivery^™ on Target Volume Particulate Distribution in Liver-Directed Embolotherapy

A Retrospective Analysis of DEM-TACE Delivered via End-hole Microcatheter vs Pressure-Enabled Drug Delivery^™ in Patients with HCC

Podcasts Related to Cancer Treatment

Bridging to Transplant with Dr. Jen Berumen and Dr. Isabel Newton

Episode 64

Locoregional Therapies for HCC with Dr. Alex Kim

Episode 67

Targeting the Tumor Microenvironment with Dr. Terence Gade

Episode 76

IO in Private Practice Part I with Dr. Justin Lee

Episode 91

IO in Private Practice Part 2 with Dr. Justin Lee

Episode 92

Publications

January 2019

Cardiovascular and Interventional Radiology

End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis

Titano et al.

Watch the video for more information.

September 2017

PlOS One

Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System^® for the treatment of hepatocellular carcinoma

Kim et al.

May 2015

Journal of Vascular and Interventional Radiology

The Impact of an Antireflux Catheter on Target Volume Particulate Distribution in Liver-Directed Embolotherapy: A Pilot Study

Pasciak et al.

April 2018

Journal of Vascular and Interventional Radiology

Abstract No. 133 Surefire Infusion System (SIS) hepatocellular carcinoma registry study interim results: a multicenter study of the safety, feasibility, and outcomes of the SIS expandable-tip microcatheter in DEB-TACE

Kapoor et al.

Using the TriNav Infusion System

TriNav^® Technical User Guide

Technical User Guide

Helpful information on the device and its use.

Let us tell you more.

Contact us to learn more about this improved technology for the proprietary PEDD method.

Rx Only. For the safe and proper use of the TriNav device, refer to the Instructions for Use.

Indications for Use: The TriNav Infusion System is intended for use in angiographic procedures. It delivers radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.¹

Contraindications: TriNav is not intended for use in the vasculature of the central nervous system (including the neurovasculature) or central circulatory system (including the coronary vasculature).¹

References

1. TriSalus^™ TriNav^® Infusion System, Instructions for Use.